These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11077820)

  • 21. Tongue hyperpigmentation during interferon-alpha and ribavirin therapy.
    Aguayo-Leiva I; Pérez B; Salguero I; Jaén P
    Eur J Dermatol; 2009; 19(3):291-2. PubMed ID: 19286489
    [No Abstract]   [Full Text] [Related]  

  • 22. A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin.
    Yalcin K; Degertekin H; Yildiz F; Kilinc N
    J Gastroenterol; 2003; 38(8):796-800. PubMed ID: 14505137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of chronic hepatitis C: side effects, tolerability and quality of life].
    Gournay J; Richou C
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B60-75. PubMed ID: 12180310
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chronic viral hepatitis].
    Serov VV; Aprosina ZG; Ignatova TM; Krel' PE; Sekamova SM; Tanashchuk EL; Il'iankova AA
    Vestn Ross Akad Med Nauk; 2003; (4):34-8. PubMed ID: 12741358
    [No Abstract]   [Full Text] [Related]  

  • 25. [Onset of type 1 diabetes mellitus during combination therapy of chronic hepatitis C with interferon-alpha and ribavirin].
    Christensen UB; Krogsgaard K
    Ugeskr Laeger; 2004 Mar; 166(11):1024-5. PubMed ID: 15049242
    [No Abstract]   [Full Text] [Related]  

  • 26. A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels.
    Yu ML; Dai CY; Lee LP; Hou NJ; Hsieh MY; Huang JF; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Chuang WL
    Liver Int; 2006 Dec; 26(10):1187-95. PubMed ID: 17105583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of chronic hepatitis C in special groups].
    Bourlière M; Halfon P; Portal I
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B238-47. PubMed ID: 12180296
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chronic hepatitis C: apart from antiviral treatment what other measures should be recommended?].
    Larrey D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B283-90. PubMed ID: 12180302
    [No Abstract]   [Full Text] [Related]  

  • 30. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
    Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
    Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronic hepatitis C and B. What can be accomplished with antiviral therapy].
    MMW Fortschr Med; 2007 Feb; 149(7):14. PubMed ID: 17615650
    [No Abstract]   [Full Text] [Related]  

  • 32. Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa.
    Dieterich DT; Wasserman R; Bräu N; Hassanein TI; Bini EJ; Bowers PJ; Sulkowski MS
    Am J Gastroenterol; 2003 Nov; 98(11):2491-9. PubMed ID: 14638354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy of chronic hepatitis C].
    Ferenci P
    Wien Med Wochenschr; 2000; 150(23-24):481-5. PubMed ID: 11205179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interferon alpha. Effect, indications, therapy monitoring and side-effects].
    Kraus MR; Wilms K
    Internist (Berl); 2000 Dec; 41(12):1399-404. PubMed ID: 11189075
    [No Abstract]   [Full Text] [Related]  

  • 35. [Concomitant nodular goiter during IFN and ribavirin treatment of HCV: a case report].
    Lin F; Wang HF
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):163, 166. PubMed ID: 16700133
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia.
    Hamidah A; Yong JF; Zulkifli HI; Jamal R
    Med J Malaysia; 2002 Sep; 57(3):353-6. PubMed ID: 12440276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection.
    Papastathopoulos K; Bouzas E; Naoum G; Vergados I; Tsiodras S
    J Infect; 2006 Feb; 52(2):e59-61. PubMed ID: 15951019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis treatment update: new approvals, not much news.
    Learned J
    Notes Undergr; 1998-1999 Winter; (No 38):7-8. PubMed ID: 11366197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antiviral therapy of chronic viral hepatitis].
    Trautwein C; Manns MP
    Internist (Berl); 2001 Jun; 42(6):913-23. PubMed ID: 11449639
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chronic hepatitis and cholangitis. The liver at risk].
    MMW Fortschr Med; 1999 Jun; 141(25):20-1. PubMed ID: 10897899
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.